CJC-1295 with DAC – 2mg Research Peptide
For Laboratory Research Use Only. Not for Human Consumption.
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic, tetrasubstituted peptide analogue of Growth Hormone-Releasing Hormone (GHRH 1-29). Engineered with DAC technology, it offers extended half-life and sustained GH release, making it a potent tool for investigating growth hormone modulation, IGF-1 signaling, and anabolic processes in research models.
Key Research Attributes:
Extended Half-Life: DAC modification allows binding to albumin, dramatically extending the peptide’s half-life to 6–8 days, enabling less frequent administration in long-term studies.
GH Pulsatility & IGF-1 Elevation: Stimulates endogenous growth hormone release and downstream IGF-1 production, closely mimicking natural secretion patterns.
Anabolic Effects: Studied for roles in muscle regeneration, fat metabolism, and cell proliferation in animal models.
High Potency: Demonstrates a strong GH-releasing profile even at low microgram-per-kilogram dosages in research environments.
Potential Research Applications:
Investigating growth hormone axis regulation and pituitary stimulation
Studies on muscle hypertrophy, lean mass gain, and tissue recovery
Exploring fat metabolism, mitochondrial function, and cellular repair mechanisms
Endocrine system modeling and GH/IGF-1 feedback loop analysis
Product Specifications:
Content: 2mg lyophilized CJC-1295 with DAC peptide
Purity: ≥98% (HPLC Verified)
Form: Sterile white/off-white lyophilized powder
Molecular Formula: C165H271N47O46
Half-Life: ~6–8 days (DAC extended)
Storage: Store at -20°C; reconstituted solution stable in refrigerator (2–8°C) for short-term use
Solubility: Reconstitutes in bacteriostatic water for in vitro research
Disclaimer: This compound is supplied exclusively for scientific research and laboratory use. It is not intended for human consumption, therapeutic use, or diagnostic procedures. Handle using standard laboratory safety protocols.
